1. Home
  2. PODD vs BEKE Comparison

PODD vs BEKE Comparison

Compare PODD & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • BEKE
  • Stock Information
  • Founded
  • PODD 2000
  • BEKE 2001
  • Country
  • PODD United States
  • BEKE China
  • Employees
  • PODD N/A
  • BEKE N/A
  • Industry
  • PODD Medical/Dental Instruments
  • BEKE Real Estate
  • Sector
  • PODD Health Care
  • BEKE Finance
  • Exchange
  • PODD Nasdaq
  • BEKE Nasdaq
  • Market Cap
  • PODD 21.5B
  • BEKE 25.0B
  • IPO Year
  • PODD 2007
  • BEKE 2020
  • Fundamental
  • Price
  • PODD $299.96
  • BEKE $17.77
  • Analyst Decision
  • PODD Strong Buy
  • BEKE Strong Buy
  • Analyst Count
  • PODD 19
  • BEKE 5
  • Target Price
  • PODD $320.11
  • BEKE $27.16
  • AVG Volume (30 Days)
  • PODD 858.4K
  • BEKE 11.4M
  • Earning Date
  • PODD 08-07-2025
  • BEKE 08-11-2025
  • Dividend Yield
  • PODD N/A
  • BEKE 2.03%
  • EPS Growth
  • PODD 67.46
  • BEKE 27.45
  • EPS
  • PODD 5.55
  • BEKE 0.53
  • Revenue
  • PODD $2,198,900,000.00
  • BEKE $13,837,046,929.00
  • Revenue This Year
  • PODD $24.49
  • BEKE $17.37
  • Revenue Next Year
  • PODD $17.45
  • BEKE $12.15
  • P/E Ratio
  • PODD $54.05
  • BEKE $33.77
  • Revenue Growth
  • PODD 23.48
  • BEKE 35.91
  • 52 Week Low
  • PODD $173.00
  • BEKE $12.92
  • 52 Week High
  • PODD $329.33
  • BEKE $26.05
  • Technical
  • Relative Strength Index (RSI)
  • PODD 53.70
  • BEKE 38.99
  • Support Level
  • PODD $305.07
  • BEKE $18.20
  • Resistance Level
  • PODD $316.00
  • BEKE $18.65
  • Average True Range (ATR)
  • PODD 6.33
  • BEKE 0.48
  • MACD
  • PODD -0.34
  • BEKE -0.04
  • Stochastic Oscillator
  • PODD 69.72
  • BEKE 13.47

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.

Share on Social Networks: